JP2022546597A5 - - Google Patents

Info

Publication number
JP2022546597A5
JP2022546597A5 JP2022514708A JP2022514708A JP2022546597A5 JP 2022546597 A5 JP2022546597 A5 JP 2022546597A5 JP 2022514708 A JP2022514708 A JP 2022514708A JP 2022514708 A JP2022514708 A JP 2022514708A JP 2022546597 A5 JP2022546597 A5 JP 2022546597A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
item
itr
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022514708A
Other languages
English (en)
Japanese (ja)
Other versions
JP7700101B2 (ja
JP2022546597A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049266 external-priority patent/WO2021046265A1/en
Publication of JP2022546597A publication Critical patent/JP2022546597A/ja
Publication of JP2022546597A5 publication Critical patent/JP2022546597A5/ja
Application granted granted Critical
Publication of JP7700101B2 publication Critical patent/JP7700101B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022514708A 2019-09-06 2020-09-03 閉端dnaおよび切断可能脂質を含む脂質ナノ粒子組成物ならびにそれらの使用方法 Active JP7700101B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962896980P 2019-09-06 2019-09-06
US62/896,980 2019-09-06
US201962910720P 2019-10-04 2019-10-04
US62/910,720 2019-10-04
US201962940104P 2019-11-25 2019-11-25
US62/940,104 2019-11-25
PCT/US2020/049266 WO2021046265A1 (en) 2019-09-06 2020-09-03 Lipid nanoparticle compositions comprising closed-ended dna and cleavable lipids and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2022546597A JP2022546597A (ja) 2022-11-04
JP2022546597A5 true JP2022546597A5 (cg-RX-API-DMAC7.html) 2023-09-11
JP7700101B2 JP7700101B2 (ja) 2025-06-30

Family

ID=74853052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022514708A Active JP7700101B2 (ja) 2019-09-06 2020-09-03 閉端dnaおよび切断可能脂質を含む脂質ナノ粒子組成物ならびにそれらの使用方法

Country Status (8)

Country Link
US (1) US20220280427A1 (cg-RX-API-DMAC7.html)
EP (1) EP4025196A4 (cg-RX-API-DMAC7.html)
JP (1) JP7700101B2 (cg-RX-API-DMAC7.html)
CN (1) CN114929205B (cg-RX-API-DMAC7.html)
AU (1) AU2020342668B2 (cg-RX-API-DMAC7.html)
CA (1) CA3150452A1 (cg-RX-API-DMAC7.html)
IL (1) IL291038A (cg-RX-API-DMAC7.html)
WO (1) WO2021046265A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021060440A1 (ja) * 2019-09-26 2021-04-01 日油株式会社 脂質ナノ粒子の凍結乾燥組成物
US12534435B2 (en) 2020-03-27 2026-01-27 Generation Bio Co. Lipids and nanoparticle compositions thereof
CN115968280A (zh) * 2020-05-18 2023-04-14 世代生物公司 新型脂质及其纳米颗粒组合物
AU2021307952A1 (en) * 2020-07-17 2023-03-02 Generation Bio Co. Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof
MX2023001109A (es) 2020-07-27 2023-04-24 Anjarium Biosciences Ag Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas.
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
CN117098541A (zh) 2020-11-25 2023-11-21 阿卡格拉医药公司 用于递送核酸的脂质纳米粒及相关使用方法
WO2022261101A1 (en) * 2021-06-07 2022-12-15 Generation Bio Co. Apoe and apob modified lipid nanoparticle compositions and uses thereof
CN117642380A (zh) * 2021-06-14 2024-03-01 世代生物公司 阳离子脂质及其组合物
WO2022271780A1 (en) * 2021-06-22 2022-12-29 Intellia Therapeutics, Inc. Methods for in vivo editing of a liver gene
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
US12251471B2 (en) * 2021-07-26 2025-03-18 Oregon State University Inhalable therapeutics
CN118251212A (zh) * 2021-09-30 2024-06-25 日油株式会社 用于将核酸递送至淋巴管内皮细胞的脂质纳米颗粒
CN114432502B (zh) * 2021-12-31 2023-02-03 中山大学附属第八医院(深圳福田) 一种负载op3-4多肽、抗cxcl9抗体的水凝胶及其制备方法与应用
WO2023190175A1 (ja) * 2022-03-28 2023-10-05 日油株式会社 末梢血単核細胞へ核酸を送達するための脂質ナノ粒子およびこれを用いて末梢血単核細胞へ核酸を送達する方法
JPWO2023190176A1 (cg-RX-API-DMAC7.html) * 2022-03-28 2023-10-05
WO2023230587A2 (en) 2022-05-25 2023-11-30 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
WO2024112943A1 (en) * 2022-11-22 2024-05-30 University Of Maryland, Baltimore Activated nanotherapy for sickle cell disease
WO2024140893A1 (zh) 2022-12-29 2024-07-04 辽宁键凯科技有限公司 一种类固醇-阳离子脂质化合物及其应用
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
WO2025188836A1 (en) * 2024-03-05 2025-09-12 Saliogen Therapeutics, Inc. Compositions and methods of using gene coding for treating ocular disease
WO2025213135A1 (en) * 2024-04-04 2025-10-09 The Brigham And Women's Hospital, Inc. Lipid nanoparticles for the treatment of vascular diseases
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5928906A (en) 1996-05-09 1999-07-27 Sequenom, Inc. Process for direct sequencing during template amplification
CA2289702C (en) 1997-05-14 2008-02-19 Inex Pharmaceuticals Corp. High efficiency encapsulation of charged therapeutic agents in lipid vesicles
US6320017B1 (en) 1997-12-23 2001-11-20 Inex Pharmaceuticals Corp. Polyamide oligomers
AU6814901A (en) 2000-06-01 2001-12-11 Univ North Carolina Methods and compounds for controlled release of recombinant parvovirus vectors
WO2002087541A1 (en) 2001-04-30 2002-11-07 Protiva Biotherapeutics Inc. Lipid-based formulations for gene transfer
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
EP1604022A2 (en) 2003-03-06 2005-12-14 Oligo Engine, Inc. Modulation of gene expression using dna-rna hybrids
US20050148531A1 (en) 2003-05-15 2005-07-07 Todd Hauser Modulation of gene expression using DNA-DNA hybrids
CN1882693B (zh) 2003-09-15 2012-08-15 普洛体维生物治疗公司 聚乙二醇修饰的脂质化合物及其应用
US7404969B2 (en) 2005-02-14 2008-07-29 Sirna Therapeutics, Inc. Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
JP5639338B2 (ja) 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
CA3144493A1 (en) 2006-10-03 2008-04-10 Arbutus Biopharma Corporation Lipid containing formulations
WO2008103276A2 (en) 2007-02-16 2008-08-28 Merck & Co., Inc. Compositions and methods for potentiated activity of biologicaly active molecules
EP3100718B1 (en) 2008-01-02 2019-11-27 Arbutus Biopharma Corporation Improved compositions and methods for the delivery of nucleic acids
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
EP2310440A4 (en) 2008-07-10 2013-06-05 Serina Therapeutics Inc POLYOXAZOLINES WITH INTERNAL END GROUPS, POLYOXAZOLINES MANUFACTURED FROM PROTECTED INITIAL GROUPS AND CORRESPONDING COMPOUNDS
KR20220038506A (ko) 2009-06-10 2022-03-28 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
EP3391877A1 (en) 2010-04-08 2018-10-24 The Trustees of Princeton University Preparation of lipid nanoparticles
WO2011139911A2 (en) 2010-04-29 2011-11-10 Isis Pharmaceuticals, Inc. Lipid formulated single stranded rna
US9006417B2 (en) 2010-06-30 2015-04-14 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
US20120225129A1 (en) 2010-08-20 2012-09-06 Cerulean Pharma Inc. Conjugates, particles, compositions, and related methods
ES2987915T3 (es) 2010-09-20 2024-11-18 Sirna Therapeutics Inc Nuevos lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos
EP2500434A1 (en) * 2011-03-12 2012-09-19 Association Institut de Myologie Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
EP4074693A1 (en) * 2011-06-08 2022-10-19 Translate Bio, Inc. Cleavable lipids
CA2853689C (en) 2011-11-04 2020-06-30 Nitto Denko Corporation Method of producing lipid nanoparticles for drug delivery
WO2013073480A1 (ja) * 2011-11-18 2013-05-23 日油株式会社 細胞内動態を改善したカチオン性脂質
HK1206644A1 (en) * 2012-03-29 2016-01-15 Shire Human Genetic Therapies, Inc. Lipid-derived neutral nanoparticles
CN110003066B (zh) 2013-11-18 2021-09-03 阿克丘勒斯治疗公司 用于rna递送的可电离的阳离子脂质
US10426737B2 (en) 2013-12-19 2019-10-01 Novartis Ag Lipids and lipid compositions for the delivery of active agents
CA2953341C (en) 2014-06-25 2023-01-24 Acuitas Therapeutics Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
WO2016079197A1 (en) * 2014-11-18 2016-05-26 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Delivery enhancers for conjugated sirna and lipid nanoparticles
JP6640750B2 (ja) * 2015-01-30 2020-02-05 日油株式会社 カチオン性脂質
HUE067372T2 (hu) 2015-06-29 2024-10-28 Acuitas Therapeutics Inc Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
CN108368028B (zh) 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
DK3386484T3 (da) 2015-12-10 2022-07-04 Modernatx Inc Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
US12678515B2 (en) 2015-12-30 2026-07-14 Acuitas Therapeutics, Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
EP3315125A1 (en) * 2016-10-31 2018-05-02 Silence Therapeutics (London) Ltd Lipid nanoparticle formulation
WO2018237369A2 (en) * 2017-06-23 2018-12-27 Vical Incorporated Lipid nanoparticle (lnp)-mediated delivery of a crispr-expressing plasmid dna for treating chronic hepatitis b virus infection
CA3075168A1 (en) * 2017-09-08 2019-03-14 Generation Bio Co. Modified closed-ended dna (cedna)
EP3679148A4 (en) * 2017-09-08 2021-06-09 Generation Bio Co. LIPID NANOPARTICLE FORMULATIONS FROM NONVIRAL, CAPSID-FREE DNA VECTORS
AU2019221642A1 (en) * 2018-02-14 2020-07-09 Generation Bio Co. Non-viral DNA vectors and uses thereof for antibody and fusion protein production
CA3094057C (en) * 2018-03-27 2025-04-08 Nof Corporation CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS

Similar Documents

Publication Publication Date Title
JP2023502576A5 (cg-RX-API-DMAC7.html)
JP2023518985A5 (cg-RX-API-DMAC7.html)
JP2023534043A5 (cg-RX-API-DMAC7.html)
US12252470B2 (en) Lipids and nanoparticle compositions thereof
JP2024517644A5 (cg-RX-API-DMAC7.html)
AU2020342668B2 (en) Lipid nanoparticle compositions comprising closed-ended DNA and cleavable lipids and methods of use thereof
JP2024522692A5 (cg-RX-API-DMAC7.html)
US20230320993A1 (en) Methods for encapsulating polynucleotides into reduced sizes of lipid nanoparticles and novel formulation thereof
JP2023527747A5 (cg-RX-API-DMAC7.html)
US20240293574A1 (en) Cationic lipids and compositions thereof
US20250249123A1 (en) Lipids and compositions thereof
JP2024520756A5 (cg-RX-API-DMAC7.html)
JP2024529343A5 (cg-RX-API-DMAC7.html)
US20230181764A1 (en) Novel lipids and nanoparticle compositions thereof
RU2023129760A (ru) Катионные липиды и их композиции
RU2023135629A (ru) Катионные липиды и их композиции